Icon - Our Board

Our Board

Kidney Health Australia Board of Directors

Mr David Morgan BA (Hons), M Int Law
Mr Morgan was appointed Chair of the Board June 2016.

He retired from the Department of Foreign Affairs and Trade in 2014. Mr Morgan served overseas as a diplomat and represented Australia in international trade and environment organisations. His policy experience includes helping to develop Australia’s gene technology regime and other health and safety issues.

From 2004 – 2009 Mr Morgan was a Visiting Fellow at the University of Melbourne.  

He is the author/co-author of books and journal articles on the legal, economic and political aspects of biotechnology and other trade and environment issues.

Mr Morgan is the Chair of the Emorgo Foundation and a Director of the Victorian Bridge Association.

He received a kidney from his father in 1989.

Professor Jonathan Craig PhD, MMed, FRACP, DipCH, MBChB
Prof Craig was appointed to the Board in December 2011.  

He holds a Personal Chair in Clinical Epidemiology at the University of Sydney, and is a Senior Staff Specialist at the Children’s Hospital at Westmead. He is Course Director of the Clinical Epidemiology program at the University of Sydney, and is Associate Dean of Research in the Faculty of Medicine.

Prof Craig is an internationally recognised clinician-scientist, with a focus on improving the health and wellbeing of people with chronic kidney disease, especially children and Indigenous people.

His awards include International Distinguished Medal of the National (US) Kidney Foundation (2010), TJ Neale Award for Outstanding Contribution to Nephrological Science, and Honorary Membership of the Italian Society of Nephrology (2004).

He is a past Chair of the Steering Group of the Cochrane Collaboration, is a member of NHMRC Expert Advisory Group: Structural review of NHMRC funding, and NHMRC Advisory Group on the Synthesis and Translation of Research Evidence, a member of the Pharmaceutical Benefits Advisory Committee, and Medicare Services Advisory Committee, WHO Expert Advisory Group for Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property, and The Agencey for Care Effectiveness International Advisory Panel for the Singapore Ministry of Health.

Mr Peter Jon Hartshorne
Mr Hartshorne was appointed to the Board in April 2008.

After serving a 6 year cadetship with McKinsey and Co. he went on to work for many top 100 international companies in the areas of Strategy and Technology enablement.

He is now the Managing Director, Partner and Founder of The Infinity Group [established 1994] of companies, a private professional services firm in Australia, India and UK. In addition, Mr Hartshorne is Chairman of Scholaris International Ltd., an international education based software company and Redgum Corporate Pty.Ltd. He is a member of the Remuneration and Succession Planning Committees and was appointed Chair of the Finance Committee March 2016.

Mr Graeme Holmes BEc, MBA
Mr Holmes was appointed to the Board in May 2007.  

He has over 30 years domestic and international experience in business and strategic planning and general management, Industrial Relations and Strategic Human Resource Management.  His involvement with charitable organisations includes fourteen years with Kidney Health Australia and work with the Prahran Mission.  

Mr Holmes is a member of the Finance Committee and Chairman of the Remuneration and Succession Planning Committee of Kidney Health Australia.

Mr Peter Mitchell
Mr Mitchell was appointed to the Board in May 2007.

He is currently commercial adviser to FMT Worldwide, an Australian-based software company. He also served for ten years on the Australian Advisory Board of the insurance group AIG International.

Mr Mitchell's career spans 52 years in finance with the Commonwealth Bank and Perpetual Private Clients. Mr Mitchell was a long-serving committee member and board member of the Melbourne Cricket Club. He has also previously been a board member for seven years with Kids Help Line Australia and three years as a board member with the Lasallian Foundation (Asia Pacific).

Mr David Parker AM
Mr Parker was appointed to the Board in April 2010 and was previously the Chairman of Kidney Health Australia's Naitonal Consumer Council.  

Mr Parker is currently Deputy Secretary at the Department of Agriculture and Water Resources and has partiuclar responsiblity for water, the department's economic and scientific reserach arm, the Australian Bureau of Agricultural and Resource Economics and Sciences (ABARES) as well as Exports, Trade and Market Access.  

Mr Parker was previously a Deputy Secretary in the Department of Environment and the Commonwealth Treasury.  His career at the Treasury spanned from 1984 until February 2011 and included a period working with the OECD in Paris.  Mr Parker has qualifications in economics and law and was made a Member of the Order of Australia in January 2012.

Professor Carol Pollock MB BS PhD FRACP
Professor Carol Pollock was appointed to the Board in December 2014. 

She trained as a specialist in Renal Medicine, and gained her PhD in renal physiology in 1992. She was appointed to the Professorial Chair of Medicine, University of Sydney, Royal North Shore Hospital in 2000. She is inaugural Chairman of the Board of the Northern Sydney Local Health District, which has oversight of 6 hospitals and the health of 1.7 million people in New South Wales.

She is immediate past Chair, and currently serves on the Boards of the NSW Clinical Excellence Commission and the NSW Agency for Clinical Innovation.  She has published over 220 papers in the scientific literature.

She was twice awarded the Australian and New Zealand Society of Nephrology (ANZSN) Young Investigator Award and in 2001 was awarded the highest scientific recognition of the ANZSN, the TJ Neale award.

She has previously been a member of the NSW Ministerial Advisory Council for Science and Medical Research and regularly serves on the National Health and Medical Research Council Committees, both as a member and panel Chairman. She has been a member of the Executive Committee of the International Society of Nephrology and is the Scientific Chairman of the World Congress of Nephrology meeting to be held in Hong Kong in 2013. She serves on the Board of several not-for-profit organisations in the Health and Medical Research sector.

Mr Vin Harink B Bus, CA
Mr Harink has been a Director of the Foundation since December 2004 and was Chairman of the Board and the Finance Committee from April 2010 to March 2016.  

He is currently the CEO of Veuve Property Group, a privately owned business that develops and owns early learning centres in Australia.  In addition, he is a non-executive director of Altus Group Holdings Pty Ltd and subsidiaries, a leading traffic management group with interests in Australia and the United States.  

For the six years to December 2014, Mr Harink was the Fund Manager and Senior Portfolio Manager for Arena REIT, the ASX listed social infrastructure property fund with a significant portfolio of childcare centre properties in Australia.  Until July 2008 he was the Chief Executive Officer of Austock Property Funds Management Limited and subsidiary entities which managed serveral social infrastructure poperty funds that owned childcare and other social infrastructure properties.  

Mr Harink also has over 20 years experience in coprorate finance, mergers and acquistions and capital markets as a Director of Austock Corporate Finance Limited, a partner with Deliotte Touche Tohmatsu, a Director of Deloitte Corporate Finance Limited and a Director of KPMG corporate Finance Pty Ltd.  He is a member of the Finance Committee and Remuneration Committee.

About usOur Patrons and Ambassadors
Join our community to download